Cidara Therapeutics Inc
NASDAQ:CDTX

Watchlist Manager
Cidara Therapeutics Inc Logo
Cidara Therapeutics Inc
NASDAQ:CDTX
Watchlist
Price: 14.48 USD 4.17% Market Closed
Market Cap: 101.9m USD
Have any thoughts about
Cidara Therapeutics Inc?
Write Note

Cidara Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cidara Therapeutics Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Cidara Therapeutics Inc
NASDAQ:CDTX
Total Equity
$130.9m
CAGR 3-Years
102%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is Cidara Therapeutics Inc's Total Equity?
Total Equity
130.9m USD

Based on the financial report for Jun 30, 2024, Cidara Therapeutics Inc's Total Equity amounts to 130.9m USD.

What is Cidara Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 5Y
33%

Over the last year, the Total Equity growth was 749%. The average annual Total Equity growth rates for Cidara Therapeutics Inc have been 102% over the past three years , 33% over the past five years .

Back to Top